Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer

Affiliations

• ¹ Metastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
• ² Genomics Platform, GIGA, ULiège, Liège, Belgium.
• ³ Department of Information Technology, Ghent University, Ghent, Belgium.
• ⁴ Translational Cancer Research Unit, University of Antwerp, Antwerp, Belgium.
• ⁵ Laboratory of Experimental Pathology, GIGA-Cancer, ULiège, Liège, Belgium.
• ⁶ Laboratory of Connective Tissues Biology, GIGA-Cancer, ULiège, Liège, Belgium.
• ⁷ Laboratory for Metabolism and Vascular Medicine, Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands.
• ⁸ Laboratory of Hematology, GIGA-Inflammation, Infection and Immunity, ULiège, Liège, Belgium.
• ⁹ Institut de Recherche en Cancérologie de Montpellier, Inserm U1194, Montpellier, France.
• ¹⁰ Metastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium. a.bellahcene@uliege.be.